公司资料
Catalyst Pharmaceutical 股价、新闻与催化剂
- 股票代码:
- CPRX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
31.49 USD (+0.03%)
收盘价
最后更新: 2026年7月14日
3.83B USD
市值
股价为何变动
Current closing-price context is not available for CPRX.
公司概览
业务概览
Catalyst Pharmaceuticals is a rare-neurology company focused on therapies for neuromuscular and orphan indications.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Catalyst sits in specialty biopharma.
商业模式特征
The business combines commercial rare-disease revenue with a pipeline aimed at extending the franchise into additional orphan markets.
生物医药行业定位
Catalyst is a steady orphan-drug name whose stock is driven more by commercial execution than by broad pipeline risk.
未来催化剂
- Catalyst Pharmaceuticals's catalysts are Firdapse and AGAMREE execution, along with any rare-disease or label-expansion update that deepens the franchise. The business is still driven by commercial execution in orphan disease.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。